Success Stories

PulmoBioMed Ltd. empowers clinicians and researchers to retrieve liquid and gas samples from the deep lung, entirely non-invasively, and without any contamination, to quickly, directly, and specifically indentify the cause of lung disease.

ReproGo is a pioneering biotechnology company specialising in advanced therapies medicinal products (ATMPs), focusing on stem cell reprogramming, vascular therapeutics, disease modelling, and AI-driven innovations.

Aeriogen Ltd is commercialising a process that uses naturally occurring microbes to convert carbon dioxide gas into sustainable synthetic methane (e-methane, or power-to-methane), which is a direct replacement for fossil natural gas.

Glaia is commercialising a disruptive photosynthesis enhancement technology capable of increasing crop yields and reducing the carbon footprint of agriculture.

TextureJet is revolutionising surface texturing for automotive and aerospace parts, particularly in applications like preparing surfaces for bonding or coating.

Glaia is commercialising a disruptive photosynthesis enhancement technology capable of increasing crop yields and reducing the carbon footprint of agriculture.

PeptiMatrix is a newly established University of Nottingham spinout company that provides access to an innovative, and animal-free, 3D cell culture platform for drug development and investigative research.

Natural products derived from plants are vital to many industries but sourcing these ingredients economically and sustainably is routinely a significant challenge. Edinburgh-based Green Bioactives Ltd (GBL) is pioneering an innovative plant cell culture approach to the discovery, development, and production of high-value natural plant products that promises to be an ideal solution to these problems

Founded in 2020 and based in Glasgow, NeuroVLC was formed by combining the world-class research of the free-space optical communication and neurophotonics groups, based in the University of Strathclyde’s Institute of Photonics.

Lineat Composites is creating a new carbon fibre composite material using its patented Aligned Formable Fibre Technology (AFFT).

There is no excerpt because this is a protected post.

RevoNA holds huge potential in treating currently ‘undruggable’ diseases by overcoming the challenges associated with targeting RNA.

Aston Vision Sciences (AVS) was established to meet ballooning market demand through the provision of technically advanced, high-value solutions for the ophthalmic eyecare market.

Ziylo were bought by pharmaceutical giant Novo Nordisk’s for $800m (£623m) in 2018 in a deal which gave them full rights to develop glucose responsive insulins.

Microplate Dx develops rapid antibiotic susceptibility testing diagnostic tests, enabling clinicians to confidently select the optimum antibiotic for a particular patients infection in less than 1 hour,

Interface Polymers is a spin-out from the University of Warwick. Its unique Polarfin® additive technology is able to modify the properties of common plastics to enable them to stick to and mix with other materials.

ViridiCO2 is revolutionising the sustainability of chemical manufacturing processes by deriving products from carbon dioxide (CO2) feedstocks to close the carbon loop.

Magnitude Biosciences is a specialist Contract Research Organisation (CRO) which is pioneering the use of the tiny nematode worm C. elegans, to accelerate early pre-clinical drug development for biotech and pharma.

Atelerix, a spin-out from Newcastle University, is revolutionising the way that cells are stored and transported.

Holiferm’s long term vision is to manufacture of holistically sustainable bioproducts at a value point at which they are affordable to everyone and therefore obliterate petrochemicals.

Quantum Dice aims to protect a connected future by harnessing the fundamental quantum properties of light for provable, secure encryption.

TRUEinvivo is revolutionising the success of radiotherapy treatments through its use of specially designed micro silica beads that can measure the exact dose of radiation a patient receives.

Revolution Fibres uses electrospinning to turn polymer materials into nanofibres that have a huge range of uses. From flexible sensors, filters of nano-sized pollutant particles, to next-generation composites, Revolution Fibres is a game-changing manufacturing platform.

Inductosense Limited is a spin-out from the University of Bristol that has designs and manufactures compact, wireless, sensors for the fast, repeatable detection and monitoring of corrosion or other defects in pipework and vessels.

CellRev aims to revolutionise the way cells are grown in the lab. It is developing ground-breaking technologies to make the culturing of cells more efficient and affordable.

Azul Optics has developed a new technology to assess our eye’s natural protection against harmful blue light and oxidative damage (macular pigment density).

AMLo Biosciences is a spin-out company from the University of Newcastle which develops a suite of tests to help improve the management of patients with skin cancers.

AccelerComm is a spin-out from the University of Southampton. It offers game-changing technologies to enable 5G wireless systems to be 10-times faster than 4G, laying down the foundations for the future of wireless applications and services.

CryoLogyx makes pre-plated assay ready cells. There products enable researchers to carry out months of work in a few days, by removing the need for in house cell culture. Our cell-based products are usable directly from the freezer. This eliminates around 2 weeks of cell expansion and preparatory work, 86% of single use plastic waste, and increases lab productivity and profitability.

MetalloBio is developing a novel antimicrobial platform technology. The platform is being developed as a systemic antimicrobial and as a medical device coating, giving the capability to both prevent and treat multidrug resistant infections.

DINETCQ is a sports spin out from Loughborough University combining Sports biomechanics, expert coaching know-how and Artificial Intelligence.

SensiBile is developing a point of care test to detect the quality of donor organs before transplantation.

digiLab is a deep tech company providing decision confidence in safety critical industries using its proprietary ML/AI platform twinLab.

Bia Analytical Ltd is a UK food authentication testing laboratory set up to address concerns about economically motivated adulteration.

Halcyon 3D Ltd produces additives for 3D photolithographical resins to reduce stress and deformation in 3D photo printing.

Erebagen is a synthetic biology company that discovers, optimises & scales truly novel bioactive products from microbes by activating previously silent gene clusters.

Smytec has created the first non-contact, non-destructive forensic evidence retrieval technique for searching, locating, identifying and recovering various forensic evidence types.

OGI Bio is revolutionising how bacteria, yeast and algae are grown and analysed with a modular culturing system that allows our customer to manage features for their culturing process.

NanoSyrinx is a discovery stage synthetic biology company creating a next-generation platform technology for the targeted intracellular delivery of biological medicines.

GenoME Diagnostics is a spin out company focusing on development of novel tests for early detection of diseases using an affordableand highly scalable platform.

VascVersa is developing a cell therapy product, Angicyte, which will address the underlying cause of the condition by promoting the formation of new blood vessels.

Phlux is developing high performance infrared sensors that will dramatically improve the performance of laser rangefinder, LIDAR, fibre sensing and imaging systems.

Speak Unique has developed cutting-edge speech synthesis that is able to create personalised synthetic voices.

KOKU origins are founded on over 20 years of research in falls prevention, healthy ageing and health behaviour change theory.

ImmuOne is a spin-out company from the University of Hertfordshire specialising in human in vitro cell culture solutions for safety assessment.